BrightSpring Health Services, Inc.

Equities

BTSG

US10950A1060

Healthcare Facilities & Services

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
10.58 USD +1.63% Intraday chart for BrightSpring Health Services, Inc. +0.67% 0.00%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
BrightSpring Health Services, Inc. Appoints Timothy A. Wicks to the Board as A Class I Director and Member of the Audit Committee CI
PACS Group to raise $450 mln in US IPO at over $3 bln valuation RE
BrightSpring Health Services Appoints Olivia Kirtley to Its Board of Directors CI
BrightSpring Health Services Insider Bought Shares Worth $297,712, According to a Recent SEC Filing MT
Health services provider Concentra confidentially files for US IPO RE
BrightSpring Health Services, Inc.(NasdaqGS:BTSG) added to S&P TMI Index CI
Canada's IPO Drought Reaches a Full Year With No End In Sight MT
HSBC Starts Coverage on BrightSpring Health With Buy Rating, $13 Price Target MT
Goldman Sachs Cuts Price Target on BrightSpring Health to $23 From $26, Maintains Buy Rating MT
Sector Update: Health Care Stocks Retreat Thursday Afternoon MT
Sector Update: Health Care MT
BrightSpring Health Services Shares Fall After Q4 Loss Narrows, Revenue Rises MT
Earnings Flash (BTSG) BRIGHTSPRING HEALTH SERVICES Reports Q4 Revenue $2.38B, vs. Street Est of $2.36B MT
BrightSpring Health Services, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
BrightSpring Health Services, Inc. Provides Earnings Guidance for the Full Year of 2024 CI
Brightspring Health Services Shares Rise After Deutsche Bank Upgrade MT
Deutsche Bank Upgrades BrightSpring Health Services to Buy From Hold, $11.50 Price Target MT
Leerink Partners Starts BrightSpring Health Services With Outperform Rating, $15 Price Target MT
BofA Securities Starts BrightSpring Health Services With Buy Rating, $14 Price Target MT
UBS Initiates Brightspring Health Services at Buy Rating With $15 Price Target MT
Morgan Stanley Initiates Brightspring Health Services at Overweight Rating With $18 Price Target MT
Goldman Sachs Starts Coverage on BrightSpring Health With Buy Rating, $26 Price Target MT
Wells Fargo Initiates Brightspring Health Services at Overweight Rating With $15 Price Target MT
Jefferies Initiates Brightspring Health Services at Buy Rating With $18 Price Target MT
Moderna, Bayer-backed Metagenomi stock drops 32% on Nasdaq debut RE
Chart BrightSpring Health Services, Inc.
More charts
BrightSpring Health Services, Inc. provides a home and community-based healthcare services platform. The Company is focused on delivering complementary pharmacy and provider services to complex patients. It delivers services through two reportable segments: Pharmacy Solutions and Provider Services. It provides pharmacy services when and where demanded and as required by customers and patients in their homes and communities, often in coordination with its provider services. It delivers a variety of impactful and valuable provider services to high-need, chronic, and complex patients in home and community settings. Its platform offers complimentary pharmacy and provider services that more completely address the multiple needs of complex senior and specialty patients across their various settings and over time. Its presence spans all 50 states, it serves over 400,000 patients daily through its approximately 10,000 clinical providers and pharmacists.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
10.58 USD
Average target price
15.68 USD
Spread / Average Target
+48.22%
Consensus
  1. Stock Market
  2. Equities
  3. BTSG Stock
  4. News BrightSpring Health Services, Inc.
  5. Sector Update: Health Care Stocks Retreat Thursday Afternoon